Resources
Guides & vetted references.
A working library — the pages we send friends when they ask a question. Educational only; not medical advice.
In-depth guides
- 01Read →
How to access GLP-1 safely
A walkthrough of legitimate pathways — insurance, cash-pay branded, and compounded — with the trade-offs of each.
- 02Read →
Testing your peptides for quality
How third-party mass spectrometry works, what a COA should include, and reputable independent labs.
- 03Read →
The GLP-1 safety profile (research summary)
A plain-language digest of the STEP, SURPASS, and post-marketing surveillance data.
- 04Read →
Athletic peptide protocols
Common protocols reported in the literature for BPC-157, TB-500, and growth hormone secretagogues, with WADA context.
- 05Read →
NAD+ supplementation guide
Precursors, IV vs. oral, dosing in trials, and what endpoints have actually been measured.
- 06Read →
Reading a peptide study
A checklist for evaluating sample size, blinding, endpoints, and industry funding.
External references
Primary sources we use, cite, and recommend. We don't earn from any of these links.
- ClinicalTrials.gov ↗
Registry of active and completed trials for peptides and GLP-1 analogs.
- PubMed ↗
Primary literature search across peptide pharmacology and endocrinology.
- FDA drug shortages database ↗
Track compounding-eligible shortages for semaglutide and tirzepatide.
- USP <797> / <795> ↗
Compounding standards referenced by 503A and 503B pharmacies.
- WADA prohibited list ↗
Current status of peptides and hormones in competitive sport.